1. Complete regression of early diffuse B-cell lymphoma in an HIV-positive patient on antiretroviral therapy alone
- Author
-
Rudo Makunike-Mutasa, Leolin Katsidzira, Margaret Borok, and A Ramsay
- Subjects
Adult ,Male ,Oncology ,medicine.medical_specialty ,Lymphoma, B-Cell ,Anti-HIV Agents ,Human immunodeficiency virus (HIV) ,HIV Infections ,Dermatology ,CHOP ,medicine.disease_cause ,Antiretroviral Therapy, Highly Active ,hemic and lymphatic diseases ,Internal medicine ,Complete regression ,medicine ,Humans ,Pharmacology (medical) ,B-cell lymphoma ,Microscopy ,Histocytochemistry ,business.industry ,Public Health, Environmental and Occupational Health ,Antigens, CD20 ,Positive patient ,medicine.disease ,Immunohistochemistry ,Antiretroviral therapy ,Lymphoma ,Non-Hodgkin's lymphoma ,Infectious Diseases ,Gastric Mucosa ,Immunology ,business - Abstract
There is no evidence that antiretroviral therapy (ART) alone may result in complete remission of aggressive non-Hodgkin's lymphomas even though it improves the overall prognosis. We report a case in which early diffuse large B-cell lymphoma regressed completely after ART alone, raising the possibility that this may be sufficient therapy in selected cases.
- Published
- 2011
- Full Text
- View/download PDF